Q1 sales and EBIT topped expectations in both of the group's geographies, continuing to demonstrate Ahold Delhaize's ability to preserve LfL growth and profitability during disinflationary times. We expect limited upgrades to consensus estimates prior to the CMD, but are betting more on a gradual r
>Good, in-line Q2 results driven by metal gains - Aurubis this morning released good, in-line Q2 2023-24 (ended 31 March) results with operating EBITDA at € 179m, 3% below ODDO BHF and 2% below company-compiled consensus. The figure improved 13% q-o-q despite lower TC/RCs for concentrate (the benchmark stepped down to $ 80 and 8ct/lb on January 1 from $ 88.8 and 8.8ct in 2023). The pick-up was mostly driven by higher metal gains on the back of recent solid development...
>STM suffered from a weak macro environment in Q2-23/24 - Stabilus released a mixed set of results for its Q2-23/24. Reported Group sales are +1% YOY to €314m (+1% vs. ODDO BHF & css.) with an organic growth rate of +1.0%. Sales are strongly up in APAC (+12% YOY), flat in EMEA and down in the Americas (-4%). In terms of market segment Aerospace, Marine & Rail (+66% YOY), Health, Recreation& Furniture (+6%) and Automotive (+5%) with especially Powerise are showing YOY ...
EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Schlagwort(e): Quartalsergebnis/Quartalsergebnis RHÖN-KLINIKUM AG startet mit gutem ersten Quartal ins Geschäftsjahr 2024 08.05.2024 / 08:59 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Corporate News Bad Neustadt a. d. Saale | 8. Mai 2024 RHÖN-KLINIKUM AG startet mit gutem ersten Quartal ins Geschäftsjahr 2024 Die RHÖN-KLINIKUM AG, einer der führenden Gesundheitsdienstleister in Deutschland, ist solide ins Geschäftsjahr 2024 gestartet. Sowohl das Konzernergebnis und EBITDA als au...
Edison Investment Research Limited Edison issues review on Canadian General Investments (CGI): Adding to positive long-term performance record 08-May-2024 / 07:56 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 8 May 2024 Edison issues review on Canadian General Investments (CGI): Adding to positive long-term performance record Canadian General Investments (CGI) has delivered a very commendable long-term performance versus the Canadian market. Longstanding manager Greg Eckel at Morgan Meighen & Associates (MMA) is unphased by sto...
EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Quarter Results/Quarter Results RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter 08.05.2024 / 08:59 CET/CEST The issuer is solely responsible for the content of this announcement. Corporate News Bad Neustadt a. d. Saale | 8 May 2024 RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter RHÖN-KLINIKUM AG, one of the leading healthcare providers in Germany, has made a solid start to financial year 2024. Both consolidated profit and EBITDA as well as revenues rose in the fi...
Camurus reported its Q1 2024 results, where i) total revenues came in at SEK 390m (vs css SEK 405m, -3.7%), of which SEK 364m product sales (+3% QoQ at CER), ii) profit before tax came in at SEK 97m (vs css 80.3m, +20%), and iii) a cash position at SEK 2,274m. We observe a steady increase in the nu
Four Directors at Parker Hannifin Corp sold after exercising options/sold 5,837 shares at between 536.490USD and 548.850USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by ...
A director at Sit S.p.A bought 22,500 shares at 2.171EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
>Q1 EBITDA pre of € 101m in line with consensus of € 98m - Group sales declined by 15% y-o-y to € 1,607m (css € 1,578m) including volume decline by 5.4% y-o-y (Q4 23: -12% y/y) but up 13% q-o-q. Price erosion was 9.2% y-o-y and just -1% q-o-q. EBITDA pre of € 101m was in line with consensus/ODDO BHF estimates of € 98m and down 47% y-o-y on a high comparison base. EBITDA pre regained slightly from € 97m in Q4 2023. Activity pick-up throughout Q1 pushed receivables, wei...
>AK de 4.25 M€ finalement - Vogo a annoncé hier la finalisation de son augmentation de capital ouverte du 18 avril au 2 mai, avec maintien du DPS. Au cours de cette opération, la société a pu lever finalement 4.25 M€ brut à travers l’émission de 1.05m d’actions nouvelles. Le prix de souscription était de 4.04 € par action, traduisant une décote de 17% sur le cours de clôture de la veille du lancement de l’opération (10 avril). Le montant levé est donc légèrement en d...
>Q1 results -7.7% below consensus on top line and -4.2% on bottom line - Bechtle released Q1 results that were below our and the consensus expectations. Revenue declined by -2.3% y-o-y to € 1,503.4m, driven by a -3.8% decline y-o-y in the IT System House segment to € 932.3m. The IT E-Commerce segment was flat y-o-y at € 571.1m. EBT increased by +2.9% y-o-y to € 82.0m below our and the consensus expectations of € 85.9m and € 84.8m respectively and implying a margin of ...
MONTPELLIER, France--(BUSINESS WIRE)-- Regulatory News: La cotation des actions Medincell sur Euronext Paris a été suspendue à la demande de la Société dans l’attente de la publication d’un communiqué. La reprise des négociations sur Euronext Paris interviendra demain à l’ouverture des marchés. A propos de Medincell Medincell (Paris:MEDCL) est une société de licensing biopharmaceutique en phase clinique et commerciale qui développe des médicaments injectables à action prolongée dans de nombreux domaines thérapeutiques. Nos traitements innovants visent à garantir le respect des prescripti...
PARIS--(BUSINESS WIRE)-- (NYSE: GWRE) est ravi d’annoncer l’inauguration de son nouveau cloud center en Suisse. En sa qualité de principal Amazon Web Services (AWS) Financial Services Competency Partner, Guidewire s’est associé à AWS pour permettre aux assureurs IARD suisses d’accéder plus rapidement et plus facilement au au niveau de leur région. Cette initiative découle de la mise en œuvre d’une solution destinée à optimiser l’ingénierie du cloud et ainsi permettre aux assureurs IARD suisses de migrer vers Guidewire Cloud tout en supportant certaines exigences réglementaires spécifiques à ...
Svitzer Completes Tug Series Delivery in Brazil Rio de Janeiro – 07 May 2024 - Svitzer, a leading global towage provider, has today announced the successful delivery of Svitzer Babitonga, the final tug in a series of six sister vessels from the 2300 Rampart Series. The delivery strengthens its fleet serving Brazil's dynamic maritime industry. The completion of this milestone project underscores Svitzer's commitment to delivering safe and sustainable towage services along Brazil's coastline. Named after Babitonga Bay in Sao Francisco, where Svitzer commenced its Brazilian operations in ...
SVITZER COMPLETA ENTREGA DE SÉRIE DE REBOCADORES NO BRASIL Rio de Janeiro - 07 de maio de 2024 - A Svitzer, fornecedora líder global de reboque, anunciou hoje a entrega bem-sucedida do Svitzer Babitonga, o último rebocador de uma série de seis embarcações da série 2300 Rampart. A entrega fortalece sua frota voltada a atender o dinâmico setor marítimo do Brasil. A conclusão desse projeto ressalta o compromisso da Svitzer em fornecer serviços de reboque seguros e sustentáveis ao longo da costa brasileira. Batizada em homenagem à Baía de Babitonga, em São Francisco, onde a Svitzer iniciou ...
Tulikivi Oyj - Johdon liiketoimet: Heikki Vauhkonen TULIKIVI OYJ PÖRSSITIEDOTE 8.5.2024 KLO 10:00 Tulikivi Oyj on vastaanottanut seuraavan ilmoituksen 7.5.2024. IlmoitusvelvollinenNimi: Heikki VauhkonenAsema: ToimitusjohtajaLiikkeeseenlaskija: Tulikivi OyjLEI: 743700GSL41H2DXZY963Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 61995/4/6____________________________________________ Liiketoimen päivämäärä: 2024-05-03Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Instrumenttityyppi: OSAKEISIN: FI0009900583Liiketoimen luonne: LUOVUTUSLiiketoimien yksityi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.